MedTrace Logo

Biomarkers in Patients With Head and Neck Cancer

NCT01466257 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2017-05-19

No results posted yet for this study

Summary

RATIONALE: DNA analysis of tumor tissue may help doctors predict how well patients will respond to treatment.

PURPOSE: This research study is studying biomarkers in patients with head and neck cancer.

Conditions

Interventions

BIOLOGICAL

cetuximab

DRUG

cisplatin

GENETIC

DNA analysis

GENETIC

gene expression analysis

GENETIC

mutation analysis

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • ECOG-ACRIN Cancer Research Group

    lead NETWORK

Principal Investigators

  • Christine H. Chung, MD · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-21
Primary Completion
2012-01-01
Completion
2012-01-01

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01466257 on ClinicalTrials.gov